S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover

Abbott Laboratories (ABT) Short Interest Ratio & Short Volume

$119.46
+0.44 (+0.37%)
(As of 02/23/2024 ET)

Abbott Laboratories Short Interest Data

Current Short Volume
12,700,000 shares
Previous Short Volume
10,550,000 shares
Change Vs. Previous Month
+20.38%
Dollar Volume Sold Short
$1.44 billion
Short Interest Ratio / Days to Cover
2.3
Last Record Date
January 31, 2024
Outstanding Shares
1,735,184,000 shares
Float Size
1,720,000,000 shares
Short Percent of Float
0.74%
Today's Trading Volume
4,261,515 shares
Average Trading Volume
5,534,939 shares
Today's Volume Vs. Average
77%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Abbott Laboratories ?

Sign up to receive the latest short interest report for Abbott Laboratories and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ABT Short Interest Over Time

ABT Days to Cover Over Time

ABT Percentage of Float Shorted Over Time


Abbott Laboratories Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202412,700,000 shares $1.44 billion +20.4%0.7%2.3 $113.16
1/15/202410,550,000 shares $1.20 billion -11.2%0.6%1.9 $113.92
12/31/202311,880,000 shares $1.31 billion -3.5%0.7%2 $110.07
12/15/202312,310,000 shares $1.32 billion +4.8%0.7%2 $107.29
11/30/202311,750,000 shares $1.23 billion -2.7%0.7%2 $104.30
11/15/202312,080,000 shares $1.18 billion +22.3%0.7%2.2 $98.00
10/31/20239,880,000 shares $934.15 million +1.9%0.6%1.9 $94.55
10/15/20239,700,000 shares $881.44 million -4.7%0.6%2 $90.87
9/30/202310,180,000 shares $985.93 million -4.1%0.6%2.3 $96.85
9/15/202310,610,000 shares $1.08 billion -7.5%0.6%2.4 $101.76
8/31/202311,470,000 shares $1.18 billion -10.2%0.7%2.5 $102.90
8/15/202312,770,000 shares $1.34 billion +6.0%0.7%2.6 $104.93
7/31/202312,050,000 shares $1.34 billion +9.4%0.7%2.5 $111.34
7/15/202311,020,000 shares $1.19 billion -16.6%0.6%2.3 $107.93
6/30/202313,220,000 shares $1.44 billion +11.8%0.8%2.7 $109.02
6/15/202311,820,000 shares $1.24 billion -12.0%0.7%2.3 $105.04
5/31/202313,430,000 shares $1.37 billion +3.7%0.8%2.6 $102.00
5/15/202312,950,000 shares $1.42 billion +15.2%0.8%2.5 $109.84
4/30/202311,240,000 shares $1.24 billion -10.8%0.7%2.1 $110.47
4/15/202312,600,000 shares $1.31 billion No Change0.7%2.3 $103.96
3/31/202312,600,000 shares $1.28 billion -1.9%0.7%2.4 $101.26
3/15/202312,840,000 shares $1.26 billion -7.8%0.7%2.6 $97.80
2/28/202313,930,000 shares $1.42 billion +5.6%0.8%2.9 $101.72
2/15/202313,190,000 shares $1.42 billion +9.9%0.8%2.8 $107.28
1/31/202312,000,000 shares $1.33 billion -17.8%0.7%2.5 $110.55
1/15/202314,600,000 shares $1.66 billion -12.5%0.8%2.8 $113.51
12/30/202216,680,000 shares $1.83 billion -7.8%1.0%3 $109.79
12/15/202218,090,000 shares $1.96 billion +14.9%1.1%3.1 $108.52
11/30/202215,740,000 shares $1.69 billion +0.6%0.9%2.6 $107.58
11/15/202215,650,000 shares $1.61 billion +10.3%0.9%2.6 $103.14
10/31/202214,190,000 shares $1.40 billion +1.4%0.8%2.5 $98.94
10/15/202213,990,000 shares $1.41 billion -16.9%0.8%2.6 $100.91
9/30/202216,830,000 shares $1.63 billion +5.0%1.0%3.5 $96.76
9/15/202216,030,000 shares $1.68 billion +23.9%0.9%3.4 $105.06
8/31/202212,940,000 shares $1.33 billion -8.1%0.7%2.7 $102.65
8/15/202214,080,000 shares $1.58 billion +1.7%0.8%3 $111.90
7/31/202213,840,000 shares $1.51 billion -2.7%0.8%2.7 $108.84
7/15/202214,220,000 shares $1.55 billion +9.6%0.8%2.6 $108.82
6/30/202212,980,000 shares $1.41 billion -7.4%0.8%2.4 $108.65
6/15/202214,020,000 shares $1.47 billion +2.6%0.8%2.6 $104.80













ABT Short Interest - Frequently Asked Questions

What is Abbott Laboratories' current short interest?

Short interest is the volume of Abbott Laboratories shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 12,700,000 shares of ABT short. 0.74% of Abbott Laboratories' shares are currently sold short. Learn More on Abbott Laboratories' current short interest.

What is a good short interest ratio for Abbott Laboratories?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABT shares currently have a short interest ratio of 2.0. Learn More on Abbott Laboratories's short interest ratio.

Which institutional investors are shorting Abbott Laboratories?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abbott Laboratories: Readystate Asset Management LP, GTS Securities LLC, Barclays PLC, Wolverine Trading LLC, Paloma Partners Management Co, Parallax Volatility Advisers L.P., HAP Trading LLC, BlueCrest Capital Management Ltd, Caas Capital Management LP, Citadel Advisors LLC, Point72 Asset Management L.P., Cubist Systematic Strategies LLC, Balyasny Asset Management L.P., Verition Fund Management LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Eisler Capital US LLC, Eisler Capital UK Ltd., Goldman Sachs Group Inc., Pura Vida Investments LLC, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, IMC Chicago LLC, Wells Fargo & Company MN, UBS Group AG, Gratus Capital LLC, BNP Paribas Financial Markets, Gladius Capital Management LP, CenterStar Asset Management LLC, Concourse Financial Group Securities Inc., Wolverine Asset Management LLC, SpiderRock Advisors LLC, and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Abbott Laboratories?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.74% of Abbott Laboratories' floating shares are currently sold short.

Is Abbott Laboratories' short interest increasing or decreasing?

Abbott Laboratories saw a increase in short interest in January. As of January 31st, there was short interest totaling 12,700,000 shares, an increase of 20.4% from the previous total of 10,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Abbott Laboratories' float size?

Abbott Laboratories currently has issued a total of 1,735,180,000 shares. Some of Abbott Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Abbott Laboratories currently has a public float of 1,720,000,000 shares.

How does Abbott Laboratories' short interest compare to its competitors?

0.74% of Abbott Laboratories' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Abbott Laboratories: AstraZeneca PLC (0.13%), Thermo Fisher Scientific Inc. (0.75%), Novartis AG (0.19%), Pfizer Inc. (1.07%), Amgen Inc. (1.74%), Intuitive Surgical, Inc. (0.84%), Stryker Co. (1.18%), Elevance Health, Inc. (0.90%), Sanofi (0.18%), Medtronic plc (0.82%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Abbott Laboratories stock?

Short selling ABT is an investing strategy that aims to generate trading profit from Abbott Laboratories as its price is falling. ABT shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Abbott Laboratories?

A short squeeze for Abbott Laboratories occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABT, which in turn drives the price of the stock up even further.

How often is Abbott Laboratories' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABT, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NYSE:ABT) was last updated on 2/25/2024 by MarketBeat.com Staff